Related Experiment Videos
[Modified hemoglobin as a blood substitute in a rat model]
K Waschke1, H Krieter, D M Albrecht
1Institut für Anästhesiologie und Operative Intensivmedizin, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.
Der Anaesthesist
|February 1, 1993
Summary
Ultrapurified, polymerised bovine haemoglobin (upbHb) effectively replaced blood in rats, maintaining oxygen delivery and cardiac function. This blood substitute showed no adverse effects, indicating its potential for medical use.
Area of Science:
- Biomedical Engineering
- Cardiovascular Physiology
- Hematology
Context:
- Modified hemoglobin solutions are explored as blood substitutes.
- Ultrapurified, polymerised bovine haemoglobin (upbHb) shows promise.
- Massive hemodilution studies require careful hemodynamic monitoring.
Purpose:
- To investigate the cardiovascular and respiratory effects of massive blood replacement with upbHb in conscious rats.
- To assess the safety and efficacy of upbHb as a blood substitute.
- To evaluate hemodynamic parameters during isovolemic hemodilution.
Summary:
- Conscious rats underwent massive isovolemic hemodilution with upbHb, reducing hematocrit to <3%.
- No significant changes in cardiac index or oxygen delivery were observed over 4 hours.
- Mean arterial pressure and systemic vascular resistance increased by 30%, while stroke volume remained stable.
Impact:
- Results suggest upbHb supports adequate oxygenation and systemic delivery after extreme hemodilution.
- UpbHb demonstrated a lack of adverse cardiovascular effects unlike non-oxygen-carrying solutions.
- Further research is needed to understand the mechanisms behind the observed increase in blood pressure and vascular resistance.